KHK Sets Up R&D Center For Translational Research In Singapore
This article was originally published in PharmAsia News
Executive Summary
Kyowa Hakko Kirin has established a research-and-development center in Singapore to be operated by the Japan's drug maker's wholly owned subsidiary there.